A Review on Gastro Retentive Drug Delivery System (GRDDS)

The gastroretentive Drug Delivery System (GRDDS) is a novel method of oral medication administration that tackles significant issues with traditional systems. way to take drugs since it is convenient, patient-compliant, and flexible. Traditional oral drug delivery techniques, however, frequently encounter gastrointestinal (GI) tract restrictions, including insufficient drug release, diminished efficacy, and the requirement for frequent dosing. In order to address these issues, GRDDS extends the gastric residence time (GRT) of medications, allowing them to remain in the stomach for a longer period of time. By providing controlled, sustained drug release, improving drug absorption, and improving targeted distribution within the stomach, this extended GRT increases therapeutic efficacy and lowers the frequency of dose. This review examines the fundamentals, varieties, and advantages of GRDDS, highlighting how it can optimize drug release, boost bioavailability, and enhance overall therapy results.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-05-02
DOI
https://doi.org/10.5281/zenodo.15328412
Primary Topic
Pharmacology and Nanomedicine Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Review on Gastro Retentive Drug Delivery System (GRDDS)

Zenodo (CERN European Organization for Nuclear Research)
Pharmacology and Nanomedicine Research
article

A Review on Gastro Retentive Drug Delivery System (GRDDS)

article en

Abstract

The gastroretentive Drug Delivery System (GRDDS) is a novel method of oral medication administration that tackles significant issues with traditional systems. way to take drugs since it is convenient, patient-compliant, and flexible. Traditional oral drug delivery techniques, however, frequently encounter gastrointestinal (GI) tract restrictions, including insufficient drug release, diminished efficacy, and the requirement for frequent dosing. In order to address these issues, GRDDS extends the gastric residence time (GRT) of medications, allowing them to remain in the stomach for a longer period of time. By providing controlled, sustained drug release, improving drug absorption, and improving targeted distribution within the stomach, this extended GRT increases therapeutic efficacy and lowers the frequency of dose. This review examines the fundamentals, varieties, and advantages of GRDDS, highlighting how it can optimize drug release, boost bioavailability, and enhance overall therapy results.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 50%
Pharmacology and Nanomedicine Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.